newsfilter
← Latest News
Business Wire·

Forma Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update

Significant progress achieved with pipeline focused on rare hematologic diseases and cancers Positive Phase 1 results in patients with sickle cell disease (SCD) presented at European Hematology Association (EHA) Virtual Congress supporting etavopivat